AstraZeneca Recognizes Employee Volunteerism

AstraZeneca Logo

WILMINGTON, Del., April 19 /PRNewswire/ -- AstraZeneca (NYSE: AZN) today recognized 12 employee volunteers who were nominated to receive Jefferson Awards for public service.

Marty DeBerardinis, Director, Medicines Evaluation, was selected as the company's grand winner to travel to the National Jefferson Awards Ceremony this June in Washington, DC, where he will be considered for a national award.  

"These employees exemplify AstraZeneca's commitment to improving the health of the communities where we live and work," said David Nicoli, Vice President Corporate Affairs, AstraZeneca Pharmaceuticals LP, and Jefferson Awards Trustee and member of the National Board of Selectors. "Our company is proud of our employees who devote their time, resources and expertise to better the lives of those in need."

Sponsored by Lubrizol Life Science

[Webinar] Cannabinoid Formulation - from Farm to Pharma

Wednesday, June 24, 2020 | 12pm ET / 9am PT

A handful of cannabinoid-based pharmaceutical products are on the market today, and an ever-growing number are in the global development pipeline. This webinar will explore key considerations in developing cannabinoid-based pharmaceutical products, including an overview of global pharmaceutical cannabinoid usage today, common challenges formulating with CBD and other cannabinoids, and more.

AstraZeneca sponsors the Jefferson Awards because the company believes that the common good is best served when connections are made between patients, advocates, policymakers, healthcare providers and nonprofit organizations to address key societal and health issues.

"The twelve AstraZeneca employees honored with Jefferson Awards have made a remarkable difference in the lives of others through volunteerism," Jefferson Award co-founder Sam Beard said. "These individuals have taken action and achieved excellence in service and philanthropy."

Delaware's First Lady Carla Markell participated in the ceremony and said, "I am glad to see Delaware companies like AstraZeneca recognizing the value of volunteerism and the significant impact it can have on our local communities. Thousands of Delawareans are volunteering through work, through their communities or through portals like VolunteerDelaware.org to find ways to make a real difference."

DeBerardinis volunteers with Angel Flight Mid-Atlantic, an organization that uses over 1,500 volunteer pilots to transport patients in need to specialized medical care. DeBerardinis flies patients on his plane several times each year on his own time and at his own expense. He designs trips specific to each patient's needs that take into consideration space needed for medical equipment and the accommodation of family members, among other factors. Since becoming an Angel Flight volunteer in 2004, DeBerardinis has volunteered for more than 30 missions.

"Marty plays an important role in connecting patients to critical medical care," said Suzanne Rhodes, Director of Public Affairs, Angel Flight. "At Angel Flight we are grateful for his generosity and personalized commitment to the needs of every patient."

In addition to the grand winner, AstraZeneca recognized 11 other volunteers for their services, including:

  • Josh Carrizales, Pharmaceutical Sales Specialist
  • Letita Cheatham, Associate Toxicologist Scientist
  • Christine Clark, Executive Pharmaceutical Sales Specialist
  • John Corbett, Global Program Director
  • Patty Cozzone, Administrative Coordinator
  • Debbie Huff, Senior Analyst
  • Ron Martin, Senior Director, HR Business Planning
  • Kirsten Powell, Pharmaceutical Sales Specialist
  • Margaret Rivera, Senior Manager, Diversity & Compliance
  • Wendy Shahwan, Business Planning Liaison
  • Kristen Williams, Director, Alliances and Advocacy

 

The Jefferson Awards for Public Service, a prestigious volunteer recognition program, was founded by Jacqueline Kennedy Onassis, former US Senator Robert Taft, Jr. and Delawarean Sam Beard in 1972 to create a "Nobel Prize" for public service.  The awards are presented both nationally and locally to encourage and honor individuals for their achievements and contributions through volunteer service.  

 

About AstraZeneca

AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialization of prescription medicines.  As a leader in gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology and infectious disease medicines, AstraZeneca generated global revenues of $32.8 billion in 2009.  In the United States, AstraZeneca is a $14.8 billion healthcare business.

For more information about AstraZeneca in the US or our AZ&Me™ Prescription Savings programs, please visit: www.astrazeneca-us.com or call 1-800-AZandMe (292-6363). 

SOURCE AstraZeneca

Read more on

Suggested Articles

WuXi AppTec has appointed Celgene CAR-T program veteran David Chang to lead its cell and gene therapy CDMO, WuXi Advanced Therapies.

Maryland-based Emergent BioSolutions has won a $628 million contract with BARDA to manufacture targeted COVID-19 vaccine hopefuls.

About 76% remdesivir patients had at least one point of clinical improvement on a 7-point scale at day 11, versus 66% of patients on standard care.